483 Catalent Indiana Aug 2018

483 Catalent Indiana Aug 2018

Michele Forster FDA, Timothy Schmidt FDA$119.00 - Available Now

FDA investigators audited the Catalent Indiana - Bloomington, IN, United States facility and issued inspectional observations (via FDA 483) on 03 Aug 2018.

Product details

  • Category: Biologics
  • Inspection end: 03 Aug 2018
  • Location: Bloomington, United States
  • FEI: 3005949964
Add To Cart